Skip to content
Recall Observatory FDA recall evidence

Drug product

Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.

D-1516-2014

July 30, 2014

Class III

Product summary

Firm
Novartis Pharmaceuticals Corp.
Event
Event 68815
Status
Terminated
Classification
Class III
Quantity
50 bottles
Official record key
drug-enforcement:D-1516-2014

Official wording

Reason: Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.

Code information: Lot # PKTS, Exp 01/17

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.